The UCCC researchers conducted a study with 40 colon cancer patients and tested each patient for the enzyme ALDH1B1. They discovered 39 of the patients had significant amounts of this specific enzyme in their system, according to the news report. Identifying the enzyme may lead to earlier and more effective detection of colon cancer, researchers say.
“Other potential colon cancer biomarkers have been identified in the past,” said UCCC researcher David Orlicky. “But none thus far are present in such a high percent of the cancer cells and virtually none are overexpressed like this one.”
Read the news report about enzyme ALDH1B1 in colorectal cancer detection.
Read other coverage about colorectal cancer:
– Letter, Phone Call Improves CRC Screening Adherence, Especially Among Minorities
– Nonadvanced Adenoma Patients Can Extend Colorectal Cancer Surveillance Beyond 5 Years
– Harvard Experts Debate Benefits of Colorectal Cancer Screening Modalities
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.